Mesenchymal Stem Cells and Mononuclear Cells From Cord Blood: Cotransplantation Provides a Better Effect in Treating Myocardial Infarction

This study contributes knowledge toward effective treatment strategies for MI. Significance This study assessed cotransplantation of hematopoietic stem cells (CD34+ cells) and mesenchymal stem cells (MSCs) for treatment of myocardial infarction (MI) in a rat model. The results demonstrate that MSCs and mononuclear cells from cord blood may have synergistic effects and cotransplantation might be more effective in the treatment of MI than transplanting MSCs and CD34+ cells separately. This study contributes knowledge toward a more effective treatment protocol for MI.
Source: Stem Cells Translational Medicine - Category: Stem Cells Authors: Tags: Protocols and Manufacturing for Cell-Based Therapies, Mesenchymal Stem Cells, Hematopoietic Stem Cells Source Type: research